Anebulo Pharmaceuticals (ANEB) Income After Tax (2020 - 2025)
Anebulo Pharmaceuticals' Profit After Tax was -$2.55 million in fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with -$2.68 million a year earlier.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Income After Tax (2020 - 2025) Analysis & Trends
On a trailing twelve-month basis, Anebulo Pharmaceuticals' Profit After Tax was -$9 million through Dec 31, 2025; for FY2025 (ended Jun 30, 2025), it came in at -$9.37 million.
- In earlier fiscal years, Profit After Tax was -$8.26 million in FY2024, -$11.69 million in FY2023, -$6.82 million in FY2022 and -$3.61 million in FY2021.
- Quarterly Profit After Tax has moved between -$3.8 million (fiscal Q2 2023) and -$555,832 (fiscal Q3 2021) over five years.
- Per Business Quant data, ANEB's Profit After Tax in the three fiscal quarters before Q2 2026 was -$2.17 million (Q1 2026), -$2.24 million (Q4 2025) and -$2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Anebulo Pharmaceuticals | 11.91 Mn | -32.39 Mn | - | -2.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.55 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Sep 30, 2024 | -2.49 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -2.49 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Mar 31, 2023 | -2.78 Mn |
| Dec 31, 2022 | -3.80 Mn |
| Sep 30, 2022 | -2.61 Mn |
| Jun 30, 2022 | -2.33 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -1.55 Mn |
| Jun 30, 2021 | -2.47 Mn |
| Mar 31, 2021 | -555,832.00 |
API Access
Anebulo Pharmaceuticals Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();